Logo del repository
  1. Home
 
Opzioni

Photosensitizers binding to nucleic acids as anticancer agents

XODO, Luigi
•
RAPOZZI, Valentina
•
Cogoi, Susanna
2016
  • journal article

Periodico
FUTURE MEDICINAL CHEMISTRY
Abstract
Cationic porphyrins (Prs) and phthalocyanines (Pcs) are strong photosensitizers that have drawn much attention for their potential in photodynamic therapy. These compounds have the interesting property of binding to nucleic acids, in particular G-rich quadruplex-forming sequences in DNA and RNA. In this review, we highlight their potential as anticancer drugs.
DOI
10.4155/fmc.15.180
WOS
WOS:000369950000008
Archivio
http://hdl.handle.net/11390/1093784
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84958056600
http://www.future-science.com/loi/fmc
Diritti
closed access
Soggetti
  • B78-H1

  • cancer

  • cationic phthalocyani...

  • cationic porphyrin

  • KRAS

  • mRNA suppression

  • Panc-1

  • photodynamic therapy

  • RNA-quadruplexe

  • singlet oxygen

  • Animal

  • Antineoplastic Agent

  • DNA

  • G-Quadruplexe

  • Human

  • Indole

  • Neoplasm

  • Photochemotherapy

  • Photosensitizing Agen...

  • Porphyrin

  • RNA, Messenger

  • ras Protein

  • Drug Discovery3003 Ph...

  • Pharmacology

  • Molecular Medicine

  • Medicine (all)

Scopus© citazioni
16
Data di acquisizione
Jun 14, 2022
Vedi dettagli
Web of Science© citazioni
19
Data di acquisizione
Mar 26, 2024
Visualizzazioni
3
Data di acquisizione
Apr 19, 2024
Vedi dettagli
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback